Stock Analysis

Arca Continental. de Full Year 2023 Earnings: Revenues Disappoint

BMV:AC *
Source: Shutterstock

Arca Continental. de (BMV:AC) Full Year 2023 Results

Key Financial Results

  • Revenue: Mex$215.8b (up 2.8% from FY 2022).
  • Net income: Mex$17.5b (up 13% from FY 2022).
  • Profit margin: 8.1% (up from 7.4% in FY 2022). The increase in margin was driven by higher revenue.
  • EPS: Mex$10.33 (up from Mex$8.86 in FY 2022).
earnings-and-revenue-growth
BMV:AC * Earnings and Revenue Growth March 24th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Arca Continental. de Revenues Disappoint

Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) was mostly in line with analyst estimates.

Looking ahead, revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Beverage industry in South America.

Performance of the market in Mexico.

The company's shares are down 2.5% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 1 warning sign for Arca Continental. de that you should be aware of.

Valuation is complex, but we're helping make it simple.

Find out whether Arca Continental. de is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.